|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.32 EUR | +0.71% |
|
+3.05% | -2.43% |
| 11-26 | German Stocks Retreat on US Tariff Threats | MT |
| 11-26 | SIEMENS HEALTHINEERS : UBS reaffirms its Neutral rating | ZD |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 57.44B 60.6B 53.44B 47.7B 84.91B 5,126B 93.06B 662B 246B 2,103B 228B 223B 9,121B | P/E ratio 2025 * |
24.2x | P/E ratio 2026 * | 20.8x |
|---|---|---|---|---|---|
| Enterprise value | 69.45B 73.28B 64.62B 57.68B 103B 6,197B 113B 800B 298B 2,542B 275B 269B 11,029B | EV / Sales 2025 * |
2.94x | EV / Sales 2026 * | 2.7x |
| Free-Float |
23.56% | Yield 2025 * |
2.15% | Yield 2026 * | 2.46% |
More valuation ratios
* Estimated data
More news
Last Transcript: Siemens Healthineers AG
More recommendations
More press releases
More news
| 1 day | +0.71% | ||
| 1 week | +3.05% | ||
| 1 month | +6.98% | ||
| 3 months | -2.40% | ||
| 6 months | -3.86% | ||
| Current year | -2.43% |
1 week
49.96
51.48
1 month
47.9353.10
Current year
47.3158.14
1 year
47.3158.14
3 years
40.3267.66
5 years
28.5067.66
10 years
28.5067.66
| Director | Title | Age | Since |
|---|---|---|---|
Bernhard Montag
CEO | Chief Executive Officer | 55 | 2015-01-31 |
Jochen Schmitz
DFI | Director of Finance/CFO | 58 | 2017-11-30 |
Peter Schardt
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2018-02-28 | |
| Chairman | 63 | 2019-11-30 | |
Marion Helmes
BRD | Director/Board Member | 59 | 2018-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.90% | 18 M€ | +7.68% | ||
| 1.48% | 2 M€ | +13.56% | - | |
| 1.11% | 962 M€ | -.--% | - | |
| 1.11% | 0 M€ | +46.08% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.71% | +3.05% | -3.06% | -20.21% | 60.6B | ||
| +1.53% | +3.19% | +6.83% | -16.31% | 203B | ||
| +0.64% | -1.07% | +74.37% | +67.11% | 193B | ||
| +0.36% | +1.63% | +7.34% | -25.48% | 173B | ||
| -0.10% | +0.73% | +62.21% | +138.14% | 134B | ||
| +0.18% | -1.07% | -10.44% | -27.32% | 43.5B | ||
| -1.00% | +1.23% | +5.38% | -33.51% | 42.08B | ||
| -0.12% | +3.09% | +7.96% | -8.57% | 39.35B | ||
| +0.27% | +0.95% | +21.56% | - | 38.02B | ||
| -0.12% | +2.15% | +57.88% | -2.29% | 36.54B | ||
| Average | +0.24% | +1.65% | +23.00% | +7.95% | 96.25B | |
| Weighted average by Cap. | +0.51% | +1.52% | +29.26% | +21.04% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 23.64B 24.94B 22B 19.63B 34.95B 2,110B 38.3B 272B 101B 865B 93.71B 91.63B 3,754B | 25.12B 26.5B 23.37B 20.86B 37.13B 2,241B 40.69B 289B 108B 919B 99.55B 97.34B 3,988B |
| Net income | 2.38B 2.51B 2.22B 1.98B 3.52B 212B 3.86B 27.43B 10.21B 87.15B 9.44B 9.23B 378B | 2.77B 2.92B 2.57B 2.3B 4.09B 247B 4.48B 31.86B 11.87B 101B 10.96B 10.72B 439B |
| Net Debt | 12.01B 12.67B 11.18B 9.98B 17.76B 1,072B 19.46B 138B 51.52B 440B 47.61B 46.55B 1,907B | 10.41B 10.98B 9.68B 8.64B 15.38B 929B 16.86B 120B 44.64B 381B 41.25B 40.33B 1,652B |
More financial data
* Estimated data
Employees
72,000
Calendar
2024-12-03
- Citi Global Healthcare Conference
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-11-29 | 51.32 € | +0.71% | 485,226 |
| 24-11-28 | 50.96 € | -0.04% | 340,273 |
| 24-11-27 | 50.98 € | +0.31% | 372,856 |
| 24-11-26 | 50.82 € | +0.43% | 503,348 |
| 24-11-25 | 50.60 € | +1.61% | 794,087 |
Delayed Quote Xetra, November 29, 2024 at 11:35 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
51.32EUR
Average target price
59.62EUR
Spread / Average Target
+16.16%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SHL Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition